VRTX technical analysis

VRTX Technical Analysis

Analysis date

July 15, 2026

Market

NasdaqGS (USD)

Daily cutoff

July 14, 2026

Reliability

Passed

Informational use only. This page is not investment advice.

Data verification

VRTX Data Verification

Cross-validating the latest completed daily bar across independent sources.

Symbol
VRTX
Market
NasdaqGS
Currency
USD (US Dollar)
Latest completed bar
July 14, 2026

No adjustment factor (adjusted close equals raw close, factor 1.0). No stock splits or dividend adjustments affecting the analysis period.

SourceLatest CloseDateDifferenceStatus
Yahoo Finance Chart API (primary)476.31July 14, 2026-Verified
Finviz (independent)476.31July 14, 2026 (previous close)0.00%Verified

Bottom line

VRTX Technical Analysis Summary

VRTX (Vertex Pharmaceuticals) exhibits a mixed daily trend but a bullish weekly structure. On the daily timeframe, price at 476.31 sits below SMA20 (485.37) but above SMA50 (456.49) and SMA200 (447.88), reflecting a short-term pullback within a broader uptrend. RSI14 at 48.77 is neutral, and MACD shows the line below the signal with a negative histogram, suggesting near-term caution. The weekly timeframe is more constructive: price at 485.39 is above all key SMAs, RSI14 at 57.16 is bullish, and MACD shows a bullish crossover (line 9.81 above signal 3.15) with an expanding positive histogram at 6.66. The recent pullback from the 533.67 high aligns with a healthy correction within an intermediate-term uptrend. Key support is at 439.50 (20-day low) and 412.27 (60-day low); resistance is at 533.67 (20/60-day high). A sustained move above 485 (SMA20) would signal short-term reacceleration; a break below 439.50 would suggest deeper correction.

Multi-timeframe dashboard

Multi-Timeframe Technical Dashboard

Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.

Daily (July 14, 2026)

Trend
Mixed. Price at 476.31 is below SMA20 (485.37) but above SMA50 (456.49) and SMA200 (447.88). The short-term trend is bearish as the stock has pulled back from the 533.67 high, but the intermediate and long-term trends remain positive with price above SMA50 and SMA200.
Momentum
Neutral to slightly bearish. RSI14 at 48.77 is just below the 50 midline, indicating neutral momentum with a slight bearish tilt. MACD at 10.95 is below the signal line at 14.57, and the histogram at -3.62 is negative, reflecting declining upside momentum.
Volatility
Moderate. ATR14 at 14.70 (3.09% of price) suggests average daily movement of about 3%. Bollinger Bands (438.63 to 532.10) are wide, with price near the lower half, consistent with the recent pullback.
Volume
Below average. Latest volume of 1,093,650 is 52.8% of the 20-period average (2,073,142), indicating lower participation, which is typical during pullbacks.

Assessment

The daily timeframe shows a short-term pullback within a broader bullish structure. Price has broken below SMA20, and MACD momentum is declining. However, the stock remains above SMA50 and SMA200, which provides a supportive underlying structure. The pullback on declining volume suggests selling pressure is not intense. A recovery above SMA20 (485.37) would signal short-term reacceleration.

Weekly (July 6, 2026 week)

Trend
Bullish. Price at 485.39 is above SMA20 (453.87), SMA50 (439.90), and SMA200 (408.86). All key SMAs are sloping upward, confirming a strong long-term uptrend. The SMA200 at 408.86 is well below price, reflecting sustained multi-year appreciation.
Momentum
Bullish. RSI14 at 57.16 is above neutral and trending up. MACD at 9.81 is above the signal line at 3.15, and the positive histogram at 6.64 is expanding, indicating building bullish momentum. This represents a bullish MACD crossover.
Volatility
Moderate to elevated. ATR14 at 29.48 (6.07% of price) reflects wider weekly ranges, consistent with the biotech sector volatility and the stock pullback from the 533.67 high.
Volume
Above average. Weekly volume of 9,632,400 is 138.2% of the 20-week average (6,971,140), indicating elevated participation.

Assessment

The weekly timeframe is constructive. The bullish MACD crossover (line above signal) with an expanding histogram signals building upside momentum. Price is well above all major SMAs, confirming a strong long-term uptrend. The recent weekly pullback (1-bar return of -8.08%) appears to be a normal correction within an established uptrend. The 157.41% 252-week return underscores the multi-year appreciation.

Key indicators

VRTX Key Technical Indicators

RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.

IndicatorDailyWeekly
RSI (14)48.7757.16
MACD (12, 26, 9)10.95 / 14.57 / -3.629.81 / 3.15 / 6.64
ATR (14)14.70 (3.09%)29.48 (6.07%)
Bollinger Bands (20, 2)438.63 - 532.10400.97 - 506.76
SMA (20)485.37453.87
SMA (50)456.49439.90
SMA (200)447.88408.86

Price structure

VRTX Price Structure and Returns

Price performance across multiple lookback periods and 52-week position.

MetricDailyWeekly
Current Price476.31485.39
1-Period Return-0.82%-8.08%
5-Period Return-8.80%+8.63%
20-Period Return+7.05%+1.78%
60-Period Return+9.33%+10.66%
252-Period Return+1.59%+157.41%
52-Week Low362.50362.50
52-Week High533.67533.67
52-Week Position66.49%71.79%

Key levels

VRTX Support and Resistance Levels

Key price levels based on recent swing highs and lows across daily and weekly timeframes.

LevelDailyWeekly
20-Period High533.67533.67
20-Period Low439.50412.27
60-Period High533.67533.67
60-Period Low412.27362.50

Scenarios

VRTX Technical Scenarios

Conditions, invalidation triggers, and what to watch for each scenario.

Bullish

Trigger

Price reclaims SMA20 (485.37) and sustains above 500 with increasing volume.

Invalidation

Price breaks below the 20-day low at 439.50.

What to watch

Recovery above SMA20 (485.37) as first sign of short-term reacceleration; MACD histogram turning less negative.

Range-Bound

Trigger

Price continues to oscillate between 439.50 support and 485-500 resistance.

Invalidation

A decisive break of either boundary with increasing volume.

What to watch

RSI oscillating near 50; volume remaining below average levels.

Bearish

Trigger

Price breaks below the 20-day low at 439.50 and then the 60-day low at 412.27.

Invalidation

Price reclaims SMA20 (485.37) and holds above it.

What to watch

Sustained closes below SMA50 (456.49); increasing downside volume; MACD histogram further declining.

Methodology

Methodology and Limitations

This technical analysis uses adjusted closing prices from Yahoo Finance (primary) and Finviz (independent cross-validation). The daily analysis covers approximately 2 years (501 completed bars) ending July 14, 2026. The weekly analysis covers approximately 5 years (261 completed bars) ending the week of July 6, 2026. Prices are adjusted for dividends and stock splits using the adjusted close/raw close ratio. Volume data is from the primary source and may not match other data providers. Technical indicators include SMA, RSI, MACD, ATR, and Bollinger Bands using standard parameters. Key levels are identified from recent swing highs and lows. Technical analysis studies historical price patterns and does not constitute investment advice. It should not be used as the sole basis for trading decisions.

Frequently Asked Questions

This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.

Data sourced from Yahoo Finance (primary) and Finviz (independent cross-validation). Data cutoffs: daily July 14, 2026, weekly July 6, 2026 week. Generated July 15, 2026.